The significance of extensive HPV genotyping for cervical high-grade neoplasia among women with atypical glandular cells
American Journal of Clinical Pathology · 2025
DOI: 10.1093/ajcp/aqae103 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2025. Verfasst von Xiao Tang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections, Papillomaviridae. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Objectives
To examine the associated risk of cervical intraepithelial neoplasm grade 3+ (CIN3+) lesions in patients with AGC and extensive human papillomavirus (HPV) genotyping.
Methods
Cases with atypical glandular cell (AGC) interpretation on a Papanicolaou (Pap) test were identified along with associated extensive HPV genotyping and histologic follow-up results.
Results
Within this cohort of 469,694 Pap tests, 0.4% were diagnosed as AGCs. In total, 1267 cases had concurrent high-risk HPV (hrHPV) genotyping, and 40.3% were hrHPV positive. The percentage of AGC cases with cervical CIN3+ on histologic follow-up was 52.2% when hrHPV was positive, whereas it was 4.9% with a negative hrHPV result. The top 5 hrHPV genotypes associated with cervical CIN3+ in this cohort were HPV16, HPV18, HPV58, HPV52, and HPV33. Indeed, 92.8% of the hrHPV-associated CIN3+ lesions identified in this cohort were positive for at least one of these HPV genotypes. The sensitivity of detecting cervical CIN3+ lesions was 85.6% with the top 5 hrHPV genotypes (HPV16/18/58/52/33) and only increased to 89.0% when the additional 12 genotypes were included.
Conclusions
In patients with an AGC Pap, the risk of having a cervical CIN3+ lesion is greatly increased by positivity for hrHPV types 16, 18, 58, 52, and/or 33. Incorporating comprehensive HPV genotyping into AGC cytology allows for refined risk stratification and more tailored management strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology and Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China.
- Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China.
- Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, US.
- Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Chengquan Zhao
Zitieren
APA
Tang, X., Zilla, M. L., Jiang, W., He, Y., Starr, D., Li, L., Tong, L., Wang, C., Wang, W., Yang, K., Yin, R., & Zhao, C. (2025). The significance of extensive HPV genotyping for cervical high-grade neoplasia among women with atypical glandular cells. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqae103
Vancouver
Tang X, Zilla ML, Jiang W, He Y, Starr D, Li L, et al. The significance of extensive HPV genotyping for cervical high-grade neoplasia among women with atypical glandular cells. American Journal of Clinical Pathology. 2025. doi:10.1093/ajcp/aqae103
BibTeX
@article{Tang2025,
author = {Tang, Xiao and Zilla, Megan L and Jiang, Wei and He, Yanmei and Starr, David and Li, Lei and Tong, Lingling and Wang, Cheng and Wang, Wei and Yang, Kaixuan and Yin, Rutie and Zhao, Chengquan},
title = {The significance of extensive HPV genotyping for cervical high-grade neoplasia among women with atypical glandular cells},
journal = {American Journal of Clinical Pathology},
year = {2025},
doi = {10.1093/ajcp/aqae103}
}
EUVIMED